LOCUS       NM_001302688            1248 bp    mRNA    linear   PRI 01-NOV-2020
DEFINITION  Homo sapiens apolipoprotein E (APOE), transcript variant 1, mRNA.
ACCESSION   NM_001302688 XM_005258867
VERSION     NM_001302688.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 1248)
  AUTHORS   Kuo CL, Pilling LC, Atkins JL, Masoli JAH, Delgado J, Kuchel GA and
            Melzer D.
  TITLE     APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank
            Community Cohort
  JOURNAL   J Gerontol A Biol Sci Med Sci 75 (11), 2231-2232 (2020)
   PUBMED   32451547
  REMARK    GeneRIF: APOE e4 Genotype Predicts Severe COVID-19 in the UK
            Biobank Community Cohort.
REFERENCE   2  (bases 1 to 1248)
  AUTHORS   Goldberg TE, Huey ED and Devanand DP.
  TITLE     Association of APOE e2 genotype with Alzheimer's and
            non-Alzheimer's neurodegenerative pathologies
  JOURNAL   Nat Commun 11 (1), 4727 (2020)
   PUBMED   32948752
  REMARK    GeneRIF: Association of APOE e2 genotype with Alzheimer's and
            non-Alzheimer's neurodegenerative pathologies.
            Publication Status: Online-Only
REFERENCE   3  (bases 1 to 1248)
  AUTHORS   Saddiki H, Fayosse A, Cognat E, Sabia S, Engelborghs S, Wallon D,
            Alexopoulos P, Blennow K, Zetterberg H, Parnetti L, Zerr I, Hermann
            P, Gabelle A, Boada M, Orellana A, de Rojas I, Lilamand M, Bjerke
            M, Van Broeckhoven C, Farotti L, Salvadori N, Diehl-Schmid J,
            Grimmer T, Hourregue C, Dugravot A, Nicolas G, Laplanche JL,
            Lehmann S, Bouaziz-Amar E, Hugon J, Tzourio C, Singh-Manoux A,
            Paquet C and Dumurgier J.
  CONSRTM   Alzheimer's Disease Neuroimaging Initiative
  TITLE     Age and the association between apolipoprotein E genotype and
            Alzheimer disease: A cerebrospinal fluid biomarker-based
            case-control study
  JOURNAL   PLoS Med 17 (8), e1003289 (2020)
   PUBMED   32817639
  REMARK    GeneRIF: Age and the association between apolipoprotein E genotype
            and Alzheimer disease: A cerebrospinal fluid biomarker-based
            case-control study.
            Publication Status: Online-Only
REFERENCE   4  (bases 1 to 1248)
  AUTHORS   Farup PG, Rootwelt H and Hestad K.
  TITLE     APOE - a genetic marker of comorbidity in subjects with morbid
            obesity
  JOURNAL   BMC Med Genet 21 (1), 146 (2020)
   PUBMED   32646381
  REMARK    GeneRIF: APOE - a genetic marker of comorbidity in subjects with
            morbid obesity.
            Publication Status: Online-Only
REFERENCE   5  (bases 1 to 1248)
  AUTHORS   Greyshock,N., Guyton,J.R., Sebastian,S. and Okorodudu,D.
  TITLE     APOE p.Leu167del-Related Lipid Disorders - RETIRED CHAPTER, FOR
            HISTORICAL REFERENCE ONLY
  JOURNAL   (in) Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens
            K and Amemiya A (Eds.);
            GENEREVIEWS((R));
            (1993)
   PUBMED   24921113
REFERENCE   6  (bases 1 to 1248)
  AUTHORS   Bird,T.D.
  TITLE     Alzheimer Disease Overview
  JOURNAL   (in) Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens
            K and Amemiya A (Eds.);
            GENEREVIEWS((R));
            (1993)
   PUBMED   20301340
REFERENCE   7  (bases 1 to 1248)
  AUTHORS   McLean,J.W., Elshourbagy,N.A., Chang,D.J., Mahley,R.W. and
            Taylor,J.M.
  TITLE     Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing
            of a new variant
  JOURNAL   J Biol Chem 259 (10), 6498-6504 (1984)
   PUBMED   6327682
REFERENCE   8  (bases 1 to 1248)
  AUTHORS   Utermann,G., Pruin,N. and Steinmetz,A.
  TITLE     Polymorphism of apolipoprotein E. III. Effect of a single
            polymorphic gene locus on plasma lipid levels in man
  JOURNAL   Clin Genet 15 (1), 63-72 (1979)
   PUBMED   759055
REFERENCE   9  (bases 1 to 1248)
  AUTHORS   Innerarity,T.L., Mahley,R.W., Weisgraber,K.H. and Bersot,T.P.
  TITLE     Apoprotein (E--A-II) complex of human plasma lipoproteins. II.
            Receptor binding activity of a high density lipoprotein subfraction
            modulated by the apo(E--A-II) complex
  JOURNAL   J Biol Chem 253 (17), 6289-6295 (1978)
   PUBMED   210175
REFERENCE   10 (bases 1 to 1248)
  AUTHORS   Weisgraber,K.H. and Mahley,R.W.
  TITLE     Apoprotein (E--A-II) complex of human plasma lipoproteins. I.
            Characterization of this mixed disulfide and its identification in
            a high density lipoprotein subfraction
  JOURNAL   J Biol Chem 253 (17), 6281-6288 (1978)
   PUBMED   210174
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from HY056112.1, BM042032.1 and
            BC003557.1.
            On May 31, 2019 this sequence version replaced NM_001302688.1.
            
            Summary: The protein encoded by this gene is a major apoprotein of
            the chylomicron. It binds to a specific liver and peripheral cell
            receptor, and is essential for the normal catabolism of
            triglyceride-rich lipoprotein constituents. This gene maps to
            chromosome 19 in a cluster with the related apolipoprotein C1 and
            C2 genes. Mutations in this gene result in familial
            dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III),
            in which increased plasma cholesterol and triglycerides are the
            consequence of impaired clearance of chylomicron and VLDL remnants.
            [provided by RefSeq, Jun 2016].
            
            Transcript Variant: This variant (1) represents the longest
            transcript and encodes the longer isoform (a).
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: DRR138522.303828.1,
                                           DRR138522.1108292.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA1965299, SAMEA1966682
                                           [ECO:0000348]
            ##Evidence-Data-END##
            COMPLETENESS: complete on the 3' end.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-21                HY056112.1         48-68
            22-722              BM042032.1         2-702
            723-1248            BC003557.1         617-1142
FEATURES             Location/Qualifiers
     source          1..1248
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="19"
                     /map="19q13.32"
     gene            1..1248
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="apolipoprotein E"
                     /db_xref="GeneID:348"
                     /db_xref="HGNC:HGNC:613"
                     /db_xref="MIM:107741"
     exon            1..128
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     CDS             74..1105
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="isoform a precursor is encoded by transcript
                     variant 1; apolipoprotein E3"
                     /codon_start=1
                     /product="apolipoprotein E isoform a precursor"
                     /protein_id="NP_001289617.1"
                     /db_xref="GeneID:348"
                     /db_xref="HGNC:HGNC:613"
                     /db_xref="MIM:107741"
                     /translation="MSSGASRKSWDPGNPWPPDWPITGRKMKVLWAALLVTFLAGCQA
                     KVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQ
                     ELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLV
                     QYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGL
                     SAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEV
                     KEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTS
                     AAPVPSDNH"
     sig_peptide     74..205
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="COORDINATES: ab initio prediction:SignalP:4.0"
     exon            129..194
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     exon            195..387
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     exon            388..1248
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.1.0"
     regulatory      1223..1228
                     /regulatory_class="polyA_signal_sequence"
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="hexamer: AATAAA"
     polyA_site      1248
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="major polyA site"
ORIGIN      
        1 ctactcagcc ccagcggagg tgaaggacgt ccttccccag gagccggtga gaagcgcagt
       61 cgggggcacg gggatgagct caggggcctc tagaaagagc tgggaccctg ggaacccctg
      121 gcctccagac tggccaatca caggcaggaa gatgaaggtt ctgtgggctg cgttgctggt
      181 cacattcctg gcaggatgcc aggccaaggt ggagcaagcg gtggagacag agccggagcc
      241 cgagctgcgc cagcagaccg agtggcagag cggccagcgc tgggaactgg cactgggtcg
      301 cttttgggat tacctgcgct gggtgcagac actgtctgag caggtgcagg aggagctgct
      361 cagctcccag gtcacccagg aactgagggc gctgatggac gagaccatga aggagttgaa
      421 ggcctacaaa tcggaactgg aggaacaact gaccccggtg gcggaggaga cgcgggcacg
      481 gctgtccaag gagctgcagg cggcgcaggc ccggctgggc gcggacatgg aggacgtgtg
      541 cggccgcctg gtgcagtacc gcggcgaggt gcaggccatg ctcggccaga gcaccgagga
      601 gctgcgggtg cgcctcgcct cccacctgcg caagctgcgt aagcggctcc tccgcgatgc
      661 cgatgacctg cagaagcgcc tggcagtgta ccaggccggg gcccgcgagg gcgccgagcg
      721 cggcctcagc gccatccgcg agcgcctggg gcccctggtg gaacagggcc gcgtgcgggc
      781 cgccactgtg ggctccctgg ccggccagcc gctacaggag cgggcccagg cctggggcga
      841 gcggctgcgc gcgcggatgg aggagatggg cagccggacc cgcgaccgcc tggacgaggt
      901 gaaggagcag gtggcggagg tgcgcgccaa gctggaggag caggcccagc agatacgcct
      961 gcaggccgag gccttccagg cccgcctcaa gagctggttc gagcccctgg tggaagacat
     1021 gcagcgccag tgggccgggc tggtggagaa ggtgcaggct gccgtgggca ccagcgccgc
     1081 ccctgtgccc agcgacaatc actgaacgcc gaagcctgca gccatgcgac cccacgccac
     1141 cccgtgcctc ctgcctccgc gcagcctgca gcgggagacc ctgtccccgc cccagccgtc
     1201 ctcctggggt ggaccctagt ttaataaaga ttcaccaagt ttcacgca
//

